Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Briacell Bctxl Stock Leading The Market Price At 1.06 Up 2.40 20260410 Nio Q4 Earnings Beats Estimates By 0.30 20260403 Is Enterprise Efsc Stock Safe To Buy Now Efsc Q4 Earnings Beats Estimates By 0.08 20260406 1 Is Precigen Pgen Stock Good For Short Term Price At 4.16 Up 5.58 20260406 Is Kemper Kmpb Stock In A Buying Zone Price At 23.05 Up 0.57 20260406 What QCR Holdings QCRH flagged as biggest challenges ahead Q1 2026 EPS Exceeds Expectations ONBPP Old National Bancorp Series A Depositary Shares delivers 35 percent Q4 2025 EPS beat slips 002 percent in muted session trading Monopar Therapeutics MNPR Stock Sector Perform Weakens 20260416 KVHI KVH Industries EPS crushes estimates with 296 surprise yet revenue decline and 3 stock slide signal investor caution What is pushing AGNC E Pref AGNCO stock higher AGNC E Pref posts 145 percent EPS beat outpaces estimates AMPH Amphastar posts lower than expected Q4 2025 EPS and small yearoveryear revenue dip shares edge slightly higher Is Southern SOJD stock recovering momentum Q3 2000 Profit Surprises What is the sentiment around Gladstone GOODN stock Gladstone posts 51 EPS beat topping estimates BEPJ Brook BRP latest quarterly earnings lack disclosed core financial metrics pending final reviews What systemic risk Trinity TRINI Overhead Buying 20260501 What are the biggest risks facing Elite ETS stock Amrize AMRZ Stock Risk Factors Breakdown Q1 2026 Below Expectations NLY Annaly reports slight Q1 2026 earnings beat shares edge higher on positive investor sentiment EIKN Eikon Therapeutics CEO outlines strategic pipeline expansion priorities ahead of key clinical trial milestones Japan and Southeast Asia to Strengthen Sea Lane Security Through IntelligenceSharing Initiative BlackRock BLK Q1 2026 Earnings Surprise EPS 1253 Up Significant Ultrapar UGP Q1 2026 Earnings Why the Beat Matters Qantas Faces Operational and Reputational Scrutiny After Passenger Incident Forces Flight Diversion Trump Acquires Stake in Kura Sushi USA Drawing Attention to Japanese Dining Sector Weis Markets WMK Earnings Outlook Key Metrics for Q3 2023 What Denison DNNs 418 Decline Means for Investors 20260514 Art Tech Acq ARTC Stalls at 986 Consolidation Phase 20260514 Vietnam Solar Startup Secures 15 Million Funding Amid Global Energy Market Volatility Linked to Iran Tensions US April Payrolls Surge Beyond Expectations Yet Underlying Weaknesses Emerge Century Casinos CNTY Q1 2026 Earnings Beat Revenue NA EPS 058 MultiSensor MSAI Blows Past Q1 2026 Forecasts EPS Hits 123 Indonesian Commodity Exporters Raise Concerns Over Proposed State Monopoly Dating Startups Tackle Fake Profiles with New Verification Tools PutinXi Talks Revive Stalled Power of Siberia 2 Pipeline Amid Iran War Disruptions US Equity Funds See Outflows as Investors Eye Higher Bond Yields One House Three Owners How Homeownership Costs Have Risen Across Generations AMTD Q4 2020 Earnings Massive EPS Beat Highlights Strong Operational Performance SUPV Q1 2026 Earnings Stunning EPS Beat of 270 Amid Operational Turnaround CLMB Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction UAL Q1 2026 Earnings EPS Beat Drives Stock Rally Amid Operational Discipline Lunai Bioworks Inc LNAI Q1 2026 Earnings PreRevenue Biotech Reports WiderThanExpected Loss Amid Pipeline Progress TD SYNNEX SNX Holds Gains Near Resistance After Steady Rally Afya Limited AFYA Edges Higher as Stock Holds Above Key Support Level Seaboard Corporation SEB Holds Steady Near 4900 Amidst Sector Uncertainty Adagene Inc ADAG Presses Lower Support Test in Sight After 188 Decline SIEB Q4 2025 Earnings Modest Loss Reported as Shares Edge Higher Amazons Unrivaled Dominance Why Western Retailers Struggle to Compete WTTR Q1 2026 Earnings EPS Surges 106 Above Estimates as Water Solutions Sector Strengthens SLXN Q1 2026 Earnings NarrowerThanExpected Loss Drives Surprise but Stock Declines Marker Therapeutics Q1 2026 Earnings Loss Narrows as Clinical Progress Continues